Medication info
Mirae Ciprofloxacin Tablet

Mirae Ciprofloxacin Tablet

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
Mirae Biopharmaceutical Co., Ltd.
Appearance
White, round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 199602137 · Notified 1996.02.29 · Insurance code 657500460

Summary

Main use
Treatment of bacterial infections (urinary tract, respiratory tract, gastrointestinal tract, etc.)
Who takes it
Adults
Adult dose
○ Adults: The usual dose of ciprofloxacin is 250 ~ 500 mg per dose, taken orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose, twice daily. Acute infections are usually treated for 5 ~ 10 days. Continue treatment for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose, twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) In severe infections, the dose may be increased to 750 mg per dose even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
Mirae Biopharmaceutical Co., Ltd.

Efficacy & effects

Treatment of bacterial infections (urinary tract, respiratory tract, gastrointestinal tract, etc.)

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute uncomplicated cystitis
  • acute pyelonephritis
View approved original text

This medication is effective against various bacteria including Escherichia coli, Shigella, Salmonella, Citrobacter, and Klebsiella. It is used to treat respiratory infections excluding acute bronchitis and community-acquired pneumonia, as well as various infections of the ear, nose, and throat. It is also useful for the treatment of bacterial prostatitis, urinary tract infections, gonococcal cervicitis, and urethritis. Additionally, it is effective against infections in various sites such as gastrointestinal tract, biliary tract infections, skin and soft tissue infections, and bone and joint infections. However, it should be used with caution for some mild infections only when there are no alternative treatments. This medication is used for the treatment of various bacterial infectious diseases.

How to take

Adult dose

○ Adults: The usual dose of ciprofloxacin is 250 ~ 500 mg per dose, taken orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose, twice daily. Acute infections are usually treated for 5 ~ 10 days. Continue treatment for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose, twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) In severe infections, the dose may be increased to 750 mg per dose even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. Adjust the dose as appropriate according to symptoms.

Precautions

This medication can cause serious side effects such as tendinitis and tendon rupture, peripheral neuropathy, and central nervous system adverse reactions. If such symptoms occur, discontinue the medication immediately and consult a healthcare professional. It should not be used in patients with myasthenia gravis due to the risk of exacerbation of symptoms and should only be used restrictively when other treatment options are not available. Concomitant use with corticosteroids may increase the risk of tendon rupture, so it should be avoided. This medication should not be administered to pregnant women, nursing mothers, children and adolescents in growth stages, or patients with epilepsy. Patients with severely impaired kidney function, history of seizures, and the elderly should be administered cautiously. During treatment, various side effects such as seizures, psychiatric symptoms, gastrointestinal problems, liver dysfunction, skin rashes, myalgia, and kidney issues may occur, so caution is required. Additionally, this medication can interact with other drugs, and caution should be taken when used in combination, especially with antidiabetic agents, anticoagulants, certain sedatives, and seizure medications, following the advice of healthcare professionals. Avoid strong sunlight or ultraviolet exposure while taking this medication, and consult a healthcare provider promptly if any unusual symptoms arise. In elderly patients, the risk of serious cardiovascular side effects such as aneurysm or aortic dissection may be increased, so caution is advised. In case of overdose, renal function should be closely monitored and appropriate emergency measures should be taken. Store this medication out of the reach of children and protect it from direct sunlight and ultraviolet light.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, decrease in hematocrit, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increase in INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reaction, anaphylactoid shock, serum sickness-like reaction, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory disturbances, sensory reduction, loss of taste, tremor, convulsions, vertigo, delirium, seizures, drowsiness, migraine, coordination difficulties, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, ataxia, polyneuropathy, visual disturbances, color vision disturbances, diplopia, tinnitus, hearing loss, transient hearing loss, hearing damage, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, loss of appetite, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal bloating, dyspepsia, pseudomembranous colitis, colitis with bloody stools, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, elevated bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and spasms, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, renal impairment, increased BUN, elevated serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vulvovaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, injection site rash, itching, urticaria, aortic aneurysm, aortic dissection, mitral valve regurgitation, mitral valve insufficiency, musculoskeletal disorders, psychiatric disorders, sensory disturbances, blood glucose disturbances, hypoglycemia, shock, hypotension, chest tightness, rhabdomyolysis, muscle weakness, interstitial pneumonia, cough, abnormal chest X-ray findings, eosinophilia, visual impairment, retinal detachment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a sealed container. It is also recommended to store it at room temperature, avoiding excessively hot or cold locations.

Appearance and packaging

Appearance

White, round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.